🔎 Trials Near Me

Pradžia › 2 tipo cukrinis diabetas › Minesota

2 tipo cukrinis diabetas klinikiniai tyrimai Minesota

17 tyrimai dėl 2 tipo cukrinis diabetas ieško dalyvių vietose Minesota.

Miestai Minesota

Oficialus tyrimo tekstas (anglų kalba)

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

  • Essentia Institute of Rural Health, Duluth
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06906640

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

  • Essentia Health, Duluth
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06906627

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  • International Diabetes Center, Minneapolis
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07564414

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • International Diabetes Center, Minneapolis
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07754461

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Minneapolis Heart Institute Foundation, Minneapolis
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06112418

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Mankato
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • AES - DRS - Synexus Clinical Research US, Inc. - Edina - Minneapolis, Edina
  • Mankato Clinic - East Main Street - Javara - PPDS, Mankato
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07340320

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Minneapolis
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07662213

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Health Partners, Minneapolis
Renkami dalyviai
Amžius nuo 14 iki 75 · Visoms lytims · Atnaujinta 2026-08-03 · NCT07579702

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  • International Diabetes Center, Minneapolis
  • Mayo Clinic, Rochester
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-03 · NCT07521475

Individualized Diabetes Education Assisted by CGM (IDEA-CGM)

  • University of Minnesota, Minneapolis
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-16 · NCT06784375

Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)

  • University of Minnesota, Minneapolis
Renkami dalyviai
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-06-04 · NCT07524205

A Study of Glycemic Control in Left Ventricular Assist

  • Mayo Clinic in Rochester, Rochester
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-08 · NCT05933161

The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes

  • Mayo Clinic in Rochester, Rochester
Renkami dalyviai2 fazė
Amžius nuo 25 iki 70 · Visoms lytims · Atnaujinta 2025-10-14 · NCT06976619

Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management

  • Hennepin Healthcare Research Institute, Minneapolis
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-07-29 · NCT07091487

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.